Category
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Today's News
More News
Breast cancer risk from menopause hormones may last decades

Breast cancer risk from menopause hormones may last decades

by Marilynn MarchioneIn this May 6, 2010 file photo, a radiologist checks mammograms in in Los Angeles. Women who use certain types of hormones after menopause still have an increased risk of developi

Breast cancer risk from menopause hormones may last decades

by Marilynn MarchioneIn this May 6, 2010 file photo, a radiologist checks mammograms in in Los Angeles. Women who use certain types of hormones after menopause still have an increased risk of developi
Free tool simplifies cancer research

Free tool simplifies cancer research

byKarolinska InstitutetCredit: CC0 Public DomainEvery cell contains a vast number of proteins, each of which has a specific function, for example, as a receptor for another molecule or an enzyme

Free tool simplifies cancer research

byKarolinska InstitutetCredit: CC0 Public DomainEvery cell contains a vast number of proteins, each of which has a specific function, for example, as a receptor for another molecule or an enzyme
IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul

IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul
Pregnancy-related heart failure tied to higher cancer risk

Pregnancy-related heart failure tied to higher cancer risk

(HealthDay)—Patients with peripartum cardiomyopathy (PPCM) are more likely to have cancer before PPCM diagnosis and more likely to develop cancer after PPCM, according to a study published in the Dece

Pregnancy-related heart failure tied to higher cancer risk

(HealthDay)—Patients with peripartum cardiomyopathy (PPCM) are more likely to have cancer before PPCM diagnosis and more likely to develop cancer after PPCM, according to a study published in the Dece
Shutting down backup genes leads to cancer remission in mice

Shutting down backup genes leads to cancer remission in mice

by Jim Lynch,University of MichiganAbhinav Achreja, PhD, Research Fellow at the University of Michigan Biomedical Engineering and Deepak Nagrath, Ph.D. Associate Professor of Biomedical Engineer

Shutting down backup genes leads to cancer remission in mice

by Jim Lynch,University of MichiganAbhinav Achreja, PhD, Research Fellow at the University of Michigan Biomedical Engineering and Deepak Nagrath, Ph.D. Associate Professor of Biomedical Engineer
First-in-human trial for new lung cancer immunotherapy

First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu

First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu
Dissemination of bone metastasis linked with bone remodeling

Dissemination of bone metastasis linked with bone remodeling

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainYears to decades after breast tumors have been removed, cancer may return or metastasize in other organs. Bone is frequently affected

Dissemination of bone metastasis linked with bone remodeling

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainYears to decades after breast tumors have been removed, cancer may return or metastasize in other organs. Bone is frequently affected
Many lung cancer patients receive meds that prolong QTc interval

Many lung cancer patients receive meds that prolong QTc interval

(HealthDay)—A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval, limiting their eligibility for clinical trials, according to

Many lung cancer patients receive meds that prolong QTc interval

(HealthDay)—A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval, limiting their eligibility for clinical trials, according to
A new role for a triple-negative breast cancer target

A new role for a triple-negative breast cancer target

by Katherine Unger Baillie,University of PennsylvaniaLed by Penn Vet scientists, a new study reveals that the protein deltaNp63, whichfosters the initiation and progression of triple-negat

A new role for a triple-negative breast cancer target

by Katherine Unger Baillie,University of PennsylvaniaLed by Penn Vet scientists, a new study reveals that the protein deltaNp63, whichfosters the initiation and progression of triple-negat
New optimism on myelodysplastic syndromes

New optimism on myelodysplastic syndromes

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainPhysician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have publish

New optimism on myelodysplastic syndromes

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainPhysician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have publish
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...